ΰιξπεαιγ 2 ξ"β
|
ων δϊψετδ αΰπβμιϊ: Imnovid2 Mg.
ξητωιν ϊψετδ ΰηψϊ? λπρε μΰιπγχρ δϊψετεϊ »
|
|
 αρμ δαψιΰεϊ
φεψϊ ξϊο
PER OS
ξιπεο
Hard Capsule
ωιξεω αϊψετδ
Imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.
ξρτψ ψιωεν
152 03 33955 05
ιφψο
Celgene International Sarl, Switzerland
ϊεχσ ψιωιεο μϊψετδ
06/2014 - 05/2019
ηεξψ τςιμ
|
ψιλεζ / λξεϊ αιηιγϊ ξιπεο
|
Pomalidomide |
2 MG |
ΰψιζδ
|
λξεϊ αΰψιζδ
|
ηιι ξγσ
|
ϊψετϊ ξψων
|
Blister pvc/pctfe |
3 x 7 CAPSULES |
ηεγωιν 30 |
λο |
|
|
|